Results 191 to 200 of about 788,369 (361)
ABSTRACT The global burden of diabetes mellitus disproportionately affects low‐ and middle‐income countries (LMICs), where limited healthcare infrastructure hampers timely and effective disease management. Wearable technologies, such as continuous glucose monitors (CGMs), insulin pumps, and fitness trackers, offer a transformative opportunity to bridge
Safayet Jamil +4 more
wiley +1 more source
Isolation of tetra-, penta-, hexa- and heptaacyl glycerides from stigmas of Nicotiana tabacum.
Toshiake Matsuzaki +2 more
openalex +2 more sources
Supporting Black Women in Counselor Education Through Holistic Writing Retreats
ABSTRACT This study investigates the role of the Melanin Scholars Retreat, a writing and wellness retreat that centers the voices of Black women faculty and doctoral students in counselor education, in supporting their professional and personal well‐being.
Aiesha T. Lee +6 more
wiley +1 more source
The dual burden of stigma: a scoping review of its impact on colorectal cancer patients and screening participants. [PDF]
Zhao W, Chen M, Dai J, Wang L, Li B.
europepmc +1 more source
The S 15 Self-Incompatibility Haplotype in Brassica Oleracea Includes Three S Gene Family Members Expressed in Stigmas [PDF]
Didier Cabrillac +7 more
openalex +1 more source
PEK14: A Kinesin‐4 Necessary for Male‐Derived Fertility in Arabidopsis thaliana
ABSTRACT Of the 61 kinesins annotated in Arabidopsis thaliana, many are still without assigned function. Here, we have screened an insertional mutant library of Arabidopsis pollen‐expressed kinesins for fertility defects. Insertional mutants for three kinesins showed a significant reduction in seed set.
Isabella N. Mendes +6 more
wiley +1 more source
The effect of smart pillboxes on TB stigma among adults in a cluster-randomised TB treatment trial. [PDF]
Jennings L +7 more
europepmc +1 more source
Dispelling the Stigma of Schizophrenia: II. The Impact of Information on Dangerousness [PDF]
David L. Penn +3 more
openalex +1 more source
Abstract Long‐acting cabotegravir is approved for HIV treatment and prevention. To guide management of dosing deviations and interruptions, concentration‐time profiles for monthly and every 2 months regimens were simulated using a population pharmacokinetic (PPK) model.
Kelong Han +3 more
wiley +1 more source

